Legal & General Group Plc - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,851
-72.4%
13,380
-27.5%
0.00%
Q2 2023$122,871
-33.4%
18,449
+86.7%
0.00%
Q1 2023$184,398
-11.3%
9,882
+2.1%
0.00%
Q4 2022$207,883
+94.3%
9,678
+7.5%
0.00%
Q3 2022$107,000
-6.1%
9,000
+3.5%
0.00%
Q2 2022$114,000
-35.2%
8,699
+3.6%
0.00%
Q1 2022$176,000
+4.1%
8,393
+1.0%
0.00%
Q4 2021$169,000
-32.9%
8,3140.0%0.00%
Q3 2021$252,000
+98.4%
8,314
+91.0%
0.00%
Q2 2021$127,000
-29.1%
4,352
+4.8%
0.00%
Q1 2021$179,000
-8.2%
4,152
-1.7%
0.00%
Q4 2020$195,000
+143.8%
4,224
+129.9%
0.00%
Q3 2020$80,000
-31.0%
1,837
-15.7%
0.00%
Q2 2020$116,000
+383.3%
2,179
+105.2%
0.00%
Q1 2020$24,000
+33.3%
1,062
-13.7%
0.00%
Q4 2019$18,000
+157.1%
1,230
+22.4%
0.00%
Q3 2019$7,000
-36.4%
1,0050.0%0.00%
Q2 2019$11,0001,0050.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders